Scott Dulitz
President + Chief Strategy Officer

Scott Dulitz is the general manager and P&L owner for several of TrialCard’s acquired companies (e.g. Mango Health, Policy Reporter, Canary Insights). He also leads corporate and product strategy, mergers and acquisitions (M&A), and enterprise sales and marketing. During his tenure with TrialCard, Scott has helped the company emerge as a market leader in biopharmaceutical services through a combination of transformational organic growth (e.g. two consecutive years of 40% YOY growth) and purposeful inorganic expansion (e.g. five acquisitions since 2018).

Before joining TrialCard in 2015, Scott worked for Taiho Oncology where he led the strategic design and implementation of a limited specialty pharmacy network and patient support program for an oral oncology product. Scott has also held general manager and senior leadership positions in operations, strategy and product development, IT, and enterprise sales with United BioSource Corporation (UBC), an Express Scripts company, and AccessMED, a McKesson Specialty and U.S. Oncology company. While at UBC and AccessMED, Scott developed and managed several innovative, highly utilized patient support programs for specialty drugs spanning a variety of therapeutic areas to include oncology/hematology, rheumatology, gastroenterology, immunology, nephrology, neurology, pulmonology, endocrinology, transplant, radiopharmaceuticals, and mental health.

Scott holds a Bachelor of Business Administration Information Systems from Iowa State University and an MBA with an emphasis in finance from the University of Kansas. He and his wife, Lisa, and their two children reside in Shawnee, KS. In his spare time, Scott enjoys exercising and boating at the Lake of the Ozarks.